Hepatotoxicity is one of the major reason for drug withdrawal from pharmaceutical development and clinical use. In vitro hepatotoxicity assays mimic in vivo tissue studies and in turn provide a reliable tool for safety assessment in the early stages of drug development. Creative Bioarray has developed standard and innovative in vitro models to address the need for early stage hepatotoxicity testing.

Last week at the ESPHM Congress in Florence, we presented two new scientific posters exploring the impact of early-life micro-enteral nutrition on piglet performance.
At Tonisity, we believe robust science means generating evidence across countries, production systems and commercial farm conditions, building data that reflects the realities veterinarians and producers face in the field.
These latest findings add to growing research associated with early-life nutrition, supporting gut integrity and helping piglets better cope with critical stress periods.
It was also a pleasure connecting with customers, distributors and industry colleagues in Florence. Thank you to everyone involved, especially the Tonisity team behind the research, analysis and presentation of this work.